CRIO in partnership with Pluto Health has announced the development of an integration between clinical care and clinical research. CRIO's Medical Records API delivers electronic medical records and other health histories, alongside clinical care coordination. The Pluto Health team then provides ongoing health maintenance support for potential participants. All this information is shared with patients, and with patient consent, can be shared with their clinicians and directly to principal investigators (PIs) at clinical research sites.
CRIO's partnership with Pluto Health leverages the recent trends towards patient centricity within clinical trials, focusing on addressing the patient journey in its entirey. It delivers a method to support patients' care pathways through clinical coordination, while streamlining PI workflow, and enabling patient control over their health information.
This approach goes beyond PIs access to EMR data. The approach reviews and reconciles health status before entry into the EDC, and offers care coordination tools to advance patient care alongside clinical research operations. Once review and reconciliation are completed, the source records are populated in the EDC and remote monitors can view the underlying sanitized medical records with principal investigator annotations, along with the source records. This level of transparency enhances sponsor oversight of quality and patient safety.
CRIO Announces Partnership with Pluto Health to Expand and Accelerate Clinical Trial Access. (2023, July 19). Cision PR Newsire.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.